CN Stock MarketDetailed Quotes

002020 Zhejiang Jingxin Pharmaceutical

Watchlist
  • 12.65
  • -0.17-1.33%
Not Open Dec 4 15:00 CST
10.89BMarket Cap15.10P/E (TTM)

Zhejiang Jingxin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Jingxin Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.06B
--
+7.06%
EPS
--
0.20
--
--
Analyst Rating
Strong Buy

Dec 4, 2024

Zhejiang Jingxin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.011B--
--2024/FY-- / 4.422B--
Mar 30, 20242023/FY3.999B / 4.017B--
--2020/FY3.260B / 3.786B--
--2019/FY3.647B / 3.782B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.011B--
--2024/FY-- / 4.422B--
Mar 30, 20242023/FY3.999B / 4.017B--
--2020/FY3.260B / 3.786B--
--2019/FY3.647B / 3.782B--

Unlock Free Earnings Estimates

Zhejiang Jingxin Pharmaceutical Earnings Reports

  • Jingxin Pharmaceutical: Report for the third quarter of 2024

    Oct 25 00:00

  • Zhejiang Jingxin Pharmaceutical: Half-year report for the year 2024.

    Aug 15 00:00

  • Zhejiang Jingxin Pharmaceutical: Summary of Half-Year Report in 2024.

    Aug 15 00:00

  • Jingxin Pharmaceutical: Report for the first quarter of 2024

    Apr 24 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 4, 2024

    Strong Buy

    • Strong Buy

      81.25%

    • Buy

      18.75%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data